Ketek News Archive - Ketek Side Effects

03/13/2008 - The House Energy and Commerce Committee is backing off its threat to hold HHS Secretary Michael Leavitt in contempt of Congress after he agreed to work with it to provide subpoenaed information. More>>>

FDA Names Permanent Director for Center for Drug Evaluation and Research

03/11/2008 - Commissioner of Food and Drugs Dr. Andrew C. von Eschenbach today announced, after a national search, the appointment of Janet Woodcock, M.D., as director of the agency's Center for Drug Evaluation and Research (CDER). More>>>

FDA’s Woodcock to Head Drug Center Permanently

03/10/2008 - The FDA is going to put acting drug-center head Janet Woodcock in the post permanently, people with knowledge of the matter told the WSJ.

Woodcock’s return to the job, which she’s held in an acting capacity since September, is likely to be generally welcomed by the drug industry. More>>>

FDA Chief in Very Hot Water with Congress

03/09/2008 - It now appears that the FDA Chief Andrew von Eschenbach, M.D. has committed perjury before Congress. Unlike Roger Clemens, who also seems to be putting his foot in his mouth before Congress, von Eschenbach´s actions appeared to have allowed unnecessary deaths to Americans –hardly the mission of the FDA. More>>>

Leavitt, Congressional Committee Negotiate on Ketek Documents

03/07/2008 - HHS Secretary Mike Leavitt has gone part of the way toward avoiding a possible contempt of Congress charge from the House of Representatives over his reluctance to comply with a subpoena for documents related to the FDA’s approval of sanofi-aventis’ antibiotic Ketek. More>>>

Contempt threatened in FDA oversight
-Washington Times
02/29/2008 - A Republican congressman yesterday threatened to cite the secretary of health and human services and President Bush for contempt of Congress for not responding to a subpoena related to FDA testimony last year. More>>>

Stupak Turns Up the Heat on FDA

Wall Street Journal
02/20/2008 - Rep. Bart Stupak argued for years that the U.S. Food and Drug Administration wasn't doing a good job protecting Americans from unsafe drugs. More>>>

Suits Over Antibiotic Ketek Bolstered By House Inquiry Into Faulty Testing

-Law.com
02/15/2008 - Plaintiffs in New Jersey and six other states who claim the antibiotic Ketek caused liver disease are getting a booster shot from a congressional inquiry into the clinical trials that led to FDA approval. More>>>

Congressmen Fault FDA, Aventis, IRB in Ketek Study

-FDA News
02/14/2008 - The FDA, Aventis, a contract research organization and an institutional review board (IRB) all failed to report or investigate fraud committed in a clinical trial of Aventis’ antibiotic Ketek, a House subcommittee charged. More>>>

Congress accuses HHS and FDA of contempt in Ketek case
-PharmaTimes
02/13/2008 - The latest installment in the US Congress’ investigation into the handling of data regarding the controversial antibiotic Ketek has put pressure on the drug’s maker, Sanofi-Aventis and seen government officials and drug regulators stand accused of contempt. More>>>

White House rejects subpoena

BLOOMBERG
02/13/2008 - The Bush administration has declined to comply with a congressional subpoena for documents related to Sanofi-Aventis' antibiotic Ketek. More>>>

02/12/2008 - Just when you think it’s all Vytorin all the time in Congress, they change things up a bit. Michigan Democrats John Dingell and Bart Stupak took a Vytorin break today to focus on possible problems in an early safety study of the Sanofi-Aventis antibiotic Ketek. More>>>

Panel Features Drug Maker Sanofi-Aventis Official, GAP Client who Discovered Company Knew of Fraudulent Trails

02/11/2008 - Tomorrow, February 12, Government Accountability Project (GAP) client Ann Marie Cisneros will testify at a House Subcommittee on Oversight and Investigations hearing titled “Ketek Clinical Study Fraud: What Did Aventis Know?” The hearing is set for 11:00 a.m. at 2123 Rayburn House Office Building. More>>>

01/31/2008 - The House Energy and Commerce Committee’s investigation into sanofi-aventis’ controversial antibiotic Ketek gained steam as the panel voted on subpoenas covering individuals and numerous agency documents. More>>>

Democrats work to subpoena FDA investigators

-The Hill
01/29/2008 - Frustrated House Democrats will try to subpoena several Food and Drug Administration officials Tuesday as part of an investigation into whether FDA criminal investigators sought to prosecute a drug company in connection with a flawed drug that killed several people. More>>>

If you are currently taking Ketek and have concerns about its safety, you should consult with your doctor regarding your treatment options. Under no circumstances should you discontinue taking any medication, including Ketek, without first consulting with your doctor.

If you or a loved one have experienced liver damage, liver failure, or Stevens Johnson Syndrome as a result of Ketek side effects contact the Ketek attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and Ketek attorney are standing by to answer any questions you may have regarding Ketek side effects, a possible Ketek class action lawsuit, or any other type of Ketek litigation.

Congress to Hold Off on Contempt Charges Against HHS Secretary